Published on 24 Oct 2024 on BioPharma Dive · via Yahoo Finance
GPCR drugmaker Septerna amasses $288M in IPO
Septerna upped the size of its offering twice before pricing a stock sale that raised funds for its lead candidate, a treatment for hypoparathyroidism...